National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)

Eva Rath; Michael Bonelli; Herwig Pieringer; Holger Flick; Helmut Salzer; G. Weiss; S. Winkler; Alexander Moschen; et al.

doi:10.1007/s00508-022-02062-7

National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)

Eva Rath
, Michael Bonelli
, Herwig Pieringer
, Holger Flick
, Helmut Salzer
, G. Weiss
, S. Winkler
, Alexander Moschen
, et al.

Department of Internal Medicine 4 - Pneumology and Infectious Diseases

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	751-765
Number of pages	15
Journal	Wiener klinische Wochenschrift
Volume	134
Issue number	21-22
DOIs	https://doi.org/10.1007/s00508-022-02062-7
Publication status	Published - Aug 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

302030 Internal medicine
302068 Pulmology

Access to Document

10.1007/s00508-022-02062-7

Cite this

Rath, E., Bonelli, M., Pieringer, H., Flick, H., Salzer, H., Weiss, G., Winkler, S., Moschen, A., & et al. (2022). National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs). Wiener klinische Wochenschrift, 134(21-22), 751-765. https://doi.org/10.1007/s00508-022-02062-7

Rath, Eva ; Bonelli, Michael ; Pieringer, Herwig et al. / National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs). In: Wiener klinische Wochenschrift. 2022 ; Vol. 134, No. 21-22. pp. 751-765.

@article{0b71acfd41044fbe846febdeb0d8652b,

title = "National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)",

author = "Eva Rath and Michael Bonelli and Herwig Pieringer and Holger Flick and Helmut Salzer and G. Weiss and S. Winkler and Alexander Moschen and \{et al.\}",

year = "2022",

month = aug,

doi = "10.1007/s00508-022-02062-7",

language = "English",

volume = "134",

pages = "751--765",

journal = "Wiener klinische Wochenschrift",

issn = "1613-7671",

publisher = "Springer",

number = "21-22",

}

Rath, E, Bonelli, M, Pieringer, H, Flick, H, Salzer, H, Weiss, G, Winkler, S, Moschen, A & et al. 2022, 'National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)', Wiener klinische Wochenschrift, vol. 134, no. 21-22, pp. 751-765. https://doi.org/10.1007/s00508-022-02062-7

National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs). / Rath, Eva; Bonelli, Michael; Pieringer, Herwig et al.
In: Wiener klinische Wochenschrift, Vol. 134, No. 21-22, 08.2022, p. 751-765.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)

AU - Rath, Eva

AU - Bonelli, Michael

AU - Pieringer, Herwig

AU - Flick, Holger

AU - Salzer, Helmut

AU - Weiss, G.

AU - Winkler, S.

AU - Moschen, Alexander

AU - et al., null

PY - 2022/8

Y1 - 2022/8

UR - https://pubmed.ncbi.nlm.nih.gov/36036323/

UR - https://www.scopus.com/pages/publications/85137227643

U2 - 10.1007/s00508-022-02062-7

DO - 10.1007/s00508-022-02062-7

M3 - Article

C2 - 36036323

SN - 1613-7671

VL - 134

SP - 751

EP - 765

JO - Wiener klinische Wochenschrift

JF - Wiener klinische Wochenschrift

IS - 21-22

ER -

Rath E, Bonelli M, Pieringer H, Flick H, Salzer H, Weiss G et al. National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs). Wiener klinische Wochenschrift. 2022 Aug;134(21-22):751-765. doi: 10.1007/s00508-022-02062-7

National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)

UN SDGs

Fields of science

Access to Document

Other files and links

Cite this